文献速递产科母胎医学生殖医学

234例三胎妊娠的母体、胎儿、产科及新生儿结局比较:体内受孕与体外受精及卵胞浆内单精子注射受孕

Comparison of maternal, fetal, obstetric and neonatal outcomes for 234 triplet pregnancies conceived in vivo versus IVF and ICSI conceptions.
PubMed 文献 · Reprod Biomed Online · 2023-09-26

这项单中心回顾性队列研究纳入2000年至2022年马德里La Paz大学医院随访的234例三胎妊娠,比较体内受孕组(92例)与辅助生殖技术受孕组(142例)的母体、胎儿、产科及围产结局。辅助生殖技术组宫内生长受限在调整混杂因素后仍显著更常见(调整比值比8.65,95%CI 1.66-45.03;P=0.01)。作者认为该差异可能与辅助生殖技术组孕妇年龄较大及5分钟Apgar评分≤5和脐动脉pH<7.20发生率较高有关,并建议在这些病例中行胎盘检查。

要点

  • 辅助生殖技术三胎妊娠的宫内生长受限率显著高于体内受孕三胎妊娠(调整比值比8.65,95%CI 1.66-45.03;P=0.01)。
  • 体内受孕组单绒毛膜三羊膜囊妊娠比例显著更高(P=0.02),辅助生殖技术组双绒毛膜三羊膜囊妊娠比例显著更高(P=0.003)。
  • 作者认为辅助生殖技术组宫内生长受限较多可能与孕妇年龄较大及5分钟Apgar评分≤5、脐动脉pH<7.20发生率较高有关,建议这些病例行胎盘检查。

核心结论

  • 辅助生殖技术三胎妊娠的宫内生长受限率高于体内受孕三胎妊娠。
  • 作者认为该差异可能与辅助生殖技术组孕妇年龄较大及5分钟Apgar评分≤5和脐动脉pH<7.20发生率较高有关。
  • 作者建议在这些病例中行胎盘检查以提供有价值的信息。

研究设计与样本

  • 单中心回顾性队列研究,纳入2000年至2022年马德里La Paz大学医院随访的所有三胎妊娠。
  • 共分析234例三胎妊娠:体内受孕组(自然受孕及人工授精受孕)92例,辅助生殖技术受孕组(体外受精及卵胞浆内单精子注射受孕)142例。
  • 检查孕妇特征及母体、胎儿、产科和围产结局,并进行单变量和多变量统计分析。

主要发现

  • 辅助生殖技术三胎妊娠在2000年至2010年间更常见(P=0.003)。
  • 单绒毛膜三羊膜囊妊娠比例在体内受孕组显著更高(P=0.02),双绒毛膜三羊膜囊妊娠比例在辅助生殖技术组显著更高(P=0.003)。
  • 调整混杂因素后,宫内生长受限在辅助生殖技术组仍显著更常见(调整比值比8.65,95%CI 1.66-45.03;P=0.01)。
  • 孕妇年龄(P=0.61)、先兆早产(P=0.10)、5分钟Apgar评分≤5(P=0.99)、脐动脉pH<7.20(P=0.99)及胎儿死亡(P=0.99)的差异在调整混杂因素后消失。

临床怎么用

  • 作者认为辅助生殖技术三胎妊娠中宫内生长受限较多,可能与孕妇年龄较大及5分钟Apgar评分≤5、脐动脉pH<7.20发生率较高有关。
  • 作者建议在这些病例中行胎盘检查以提供有价值的信息。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: Is there a difference in maternal, fetal, obstetric and neonatal outcomes for triplet pregnancies when comparing in vivo conceptions with those conceived by assisted reproductive technology (ART)? DESIGN: This single-centre, retrospective cohort study included all triplet pregnancies followed up at La Paz University Hospital, Madrid between 2000 and 2022. The characteristics of the pregnant women, and maternal, fetal, obstetric and perinatal outcomes were examined. Univariate and multivariate statistical analyses were performed. RESULTS: In total, 234 triplet pregnancies were analysed: 92 in the natural and assisted insemination conception group (in-vivo conception) and 142 in the in vitro fertilization and intracytoplasmic sperm injection conception group (ART conception). ART triplet pregnancies were more common between 2000 and 2010 (P = 0.003). The percentage of monochorionic triamniotic pregnancies was significantly higher (P = 0.02) in the in-vivo conception group, and the percentage of dichorionic triamniotic pregnancies was significantly higher (P = 0.003) in the ART conception group. After adjusting for confounders, intrauterine growth restriction (IUGR) remained significantly more common in the ART conception group (adjusted odds ratio 8.65, 95% CI 1.66-45.03; P = 0.01). Differences in maternal age (P = 0.61), threatened preterm labour (P = 0.10), Apgar score ≤5 at 5 min (P = 0.99), umbilical cord pH <7.20 (P = 0.99) and fetal death (P = 0.99) disappeared after adjustment for confounders. CONCLUSION: ART triplet pregnancies had a higher rate of IUGR than in vivo triplet pregnancies. This could be related to higher maternal age, and higher rates of Apgar score ≤5 at 5 min and umbilical cord pH <7.20 in these pregnancies. In these cases, placental examination could provide valuable information.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Pena-Burgos EM, Duyos-Mateo I, Pozo-Kreilinger JJ, et al. Comparison of maternal, fetal, obstetric and neonatal outcomes for 234 triplet pregnancies conceived in vivo versus IVF and ICSI conceptions. Reprod Biomed Online. 2023. PMID: 38194878. doi:10.1016/j.rbmo.2023.103419

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。